Theravance Biopharma Inc (0TB) — Long-term Investment Intensity
Theravance Biopharma Inc (0TB) has a Long-term Investment Intensity of 0.7% as of September 2025. Long-term investments of €3.03 Million represent 0.7% of total assets of €415.46 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Theravance Biopharma Inc's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Theravance Biopharma Inc Long-term Investment Intensity (2014–2021)
This chart shows how Theravance Biopharma Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2014 to 2021. As of September 2025, the intensity stands at 0.7%, reflecting long-term investments of €3.03 Million against total assets of €415.46 Million EUR. For the complete balance sheet picture, see Theravance Biopharma Inc (0TB) total assets.
Annual Long-term Investment Intensity for Theravance Biopharma Inc (2014–2021)
The table below presents the year-by-year Long-term Investment Intensity for Theravance Biopharma Inc from 2014 to 2021, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 0TB current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 18.0% | €67.54 Million | €374.82 Million | ▲ +15.3 pp |
| 2020 | 2.7% | €12.75 Million | €469.06 Million | ▲ +1.5 pp |
| 2019 | 1.2% | €4.99 Million | €408.83 Million | ▼ -0.9 pp |
| 2018 | 2.1% | €11.87 Million | €560.24 Million | ▼ -7.3 pp |
| 2017 | 9.4% | €41.59 Million | €441.40 Million | ▼ -6.2 pp |
| 2016 | 15.6% | €99.56 Million | €639.25 Million | ▼ -1.4 pp |
| 2015 | 16.9% | €50.86 Million | €300.12 Million | ▲ +1.7 pp |
| 2014 | 15.2% | €51.40 Million | €337.77 Million | — |